These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26941928)

  • 41. Decreased cardiotrophin-1 levels are associated with a lower risk of developing the metabolic syndrome in overweight/obese children after a weight loss program.
    Rendo-Urteaga T; García-Calzón S; Martínez-Ansó E; Chueca M; Oyarzabal M; Azcona-Sanjulián MC; Bustos M; Moreno-Aliaga MJ; Martínez JA; Marti A
    Metabolism; 2013 Oct; 62(10):1429-36. PubMed ID: 23856329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
    Mayneris-Perxachs J; Guerendiain M; Castellote AI; Estruch R; Covas MI; Fitó M; Salas-Salvadó J; Martínez-González MA; Aros F; Lamuela-Raventós RM; López-Sabater MC;
    Clin Nutr; 2014 Feb; 33(1):90-7. PubMed ID: 23591154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of
    Rana S; Sultana A; Bhatti AA
    J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of a Community-Based Physical Activity and Nutrition Behavior Intervention on Features of the Metabolic Syndrome: A Cluster-Randomized Controlled Trial.
    Tran VD; James AP; Lee AH; Jancey J; Howat PA; Thi Phuong Mai L
    Metab Syndr Relat Disord; 2017 Mar; 15(2):63-71. PubMed ID: 27997282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of BMI as the marker of adiposity in a metabolic syndrome severity score: Derivation and validation in predicting long-term disease outcomes.
    Gurka MJ; Filipp SL; Musani SK; Sims M; DeBoer MD
    Metabolism; 2018 Jun; 83():68-74. PubMed ID: 29410278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia.
    Tadewos A; Egeno T; Amsalu A
    BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of obesity indices in screening Chinese postmenopausal women for metabolic syndrome.
    Liu P; Ma F; Lou H; Zhu Y
    Menopause; 2014 May; 21(5):509-14. PubMed ID: 23963310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of weight loss on waist circumference and the components of the metabolic syndrome.
    Rothberg AE; McEwen LN; Kraftson AT; Ajluni N; Fowler CE; Nay CK; Miller NM; Burant CF; Herman WH
    BMJ Open Diabetes Res Care; 2017; 5(1):e000341. PubMed ID: 28316795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.
    Bressington D; Mui J; Tse ML; Gray R; Cheung EF; Chien WT
    BMC Psychiatry; 2016 Nov; 16(1):411. PubMed ID: 27863522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preventing metabolic syndrome in morbid obesity with resistance training: Reporting interindividual variability.
    Delgado-Floody P; Álvarez C; Lusa Cadore E; Flores-Opazo M; Caamaño-Navarrete F; Izquierdo M
    Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1368-1381. PubMed ID: 31383503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of metabolic syndrome among 40- and 50-year-old inhabitants of Wroclaw, Poland.
    Ilow R; Regulska-Ilow B; Różańska D; Kowalisko A; Biernat J
    Ann Agric Environ Med; 2012; 19(3):551-6. PubMed ID: 23020055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.
    Chen YH; Lee YC; Tsao YC; Lu MC; Chuang HH; Yeh WC; Tzeng IS; Chen JY
    BMJ Open; 2018 May; 8(5):e016554. PubMed ID: 29724734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health-Related Quality of Life in Tehran Lipid and Glucose Study.
    Amiri P; Jalali-Farahani S; Vahedi-Notash G; Cheraghi L; Azizi F
    Int J Endocrinol Metab; 2018 Oct; 16(4 Suppl):e84745. PubMed ID: 30584433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
    Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
    Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between Metabolic Syndrome and Health-related Quality of Life among Individuals with Normal and Impaired Glucose Regulation: Findings from Tehran Lipid and Glucose Study.
    Hatami H; Deihim T; Amiri P; Cheraghi L; Azizi F
    Arch Iran Med; 2016 Aug; 19(8):577-83. PubMed ID: 27544367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated fasting glucose levels within normal range are associated with an increased risk of metabolic syndrome in older women.
    Hsiao FC; Hsieh CH; Wu CZ; Hsu CH; Lin JD; Lee TI; Pei D; Chen YL
    Eur J Intern Med; 2013 Jul; 24(5):425-9. PubMed ID: 23647841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of medical nutrition therapy on body fat and metabolic syndrome components in premenopausal overweight women.
    Lim H; Son JY; Choue R
    Ann Nutr Metab; 2012; 61(1):47-56. PubMed ID: 22832546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.